STOCKS TELEGRAPH

Author: ST Staff

  • Paysafe Limited (PSFE) Stock Fall -7.75% Premarket, Here’s Why‎

    Paysafe Ltd. (PSFE), a company known for providing online businesses with digital commerce solutions, is currently seeing a decline in premarket, as its share price reached $9.41 after decreasing some 7.75%. This has followed after the PSFE stock declined by some 6.25% on Friday, resulting in the share price decreasing to $10.20.

    Appointment of CEO Global digital wallet

    On the 10th of August, the company announced to appoint Chirag Patel as the CEO of its Global digital wallet business. According to the company, Patel would join during early September. Patel has experience of over 20 years working with top global organizations in payments. Before joining Paysafe, he was Global head of payments at Santander group, and before that, he has also served as Amazon’s Head of payments of Europe and international expansion.“We’re thrilled to have someone of Patel’s caliber and energy-level to take our Digital Wallets business to the next level of growth”, said Philip McHugh, CEO of Paysafe. Before Patel, Lorenzo Pellegrino was the CEO of Digital wallet.

    Acquisition of PagoEffectivo

    On 2nd August, Paysafe announced to have signed a definitive agreement for the acquisition of PagoEffectivo, which is a Peruvian alternative payments (APM) platform, existing in Latin America. That agreement provided Paysafe with a foothold in the Latin American region. “Our cloud-based technology stack and global enterprise relationships will only help accelerate PagoEfectivo’s very strong growth”, said Philip McHugh on the occasion. After the news of that signing came out, PFSE stock experienced a surge in NASDAQ.

    PSFE Appointmed Non-executive director

    On the 26th of July, Paysafe announced the appointment of Mark Brooker as its non-executive director. Brooker joined as an additional member of the board. He has extensive experience in executive posts. Before that incorporation, he was the COO of Trainline, Europe’s largest retailer of rails and coaches tickets. He also has diverse experience in non-executive roles within the industry.

    Launch of safeguarding solutions

    In early July, the company announced the global launch of safeguarding solutions for the travel industry. This new solution makes the role of travel operators minimal. This solution works in a way quite different from other travel businesses. The consumer payments are held by the third party and then released in full to the travel company. That mechanism had been made in partnership between Paysafe and industry specialized trust solutions partners. Meanwhile, days before the launch of solutions, the company published a whitepaper for the industry. The paper outlined the safeguarding model could prove fruitful for both the travel business and for the acquirers as well.

    Enabled online transactions on Xbox

    In June, Paysafe announced it have extended its relation with Microsoft, via enabling online cash transactions on Xbox. The transactions had to be done through Paysafecard.  Paysafecard is currently available in 50 different countries. Initially, in December 2020, Paysafe’s e-cash payment solution was added to Xbox.” It’s an inclusive option for those who might not have traditional bank accounts and provides an easy way to manage entertainment budgets”, said Udo Müller, CEO of Paysafecard.

    What’s the future of PSFE stock?

    Looking ahead, the revenue targets of the company estimated for the next year stand at $1.71 billion. Apart from that, the growth estimates for next year stand at 433.30%. All of these stats suggest that future times seem to be jubilating for Paysafe. With regards to PSFE stock, the EPS for next year could increase by 387.50%, a factor that every potential investor should keep in mind.

  • PLX Stock on a Rise in premarket. Here’s Why

    Protalix Biotherapeutics Inc (PLX), a biopharmaceutical company, experienced a decline of 9.48% in its share price on Friday after it fell to $1.34. In the premarket, PLX stock is changing hands at $1.38, a surge of 2.99%.

    Exchange of notes

    On the 13th of August, the company announced to have entered into an agreement which was relevant to the exchange of an aggregate of $54.65 million amount of the company’s 7.50% senior secured convertible notes, due to in 2021, for an aggregate $28.75 million amount of 7.50% senior secured convertible notes, due in 2024, with a cash amount of $25.90 million as well as accrued and unpaid interest. The company expects that after the closing to exchange, the existing notes having an aggregate principal amount of $3.27 million would remain outstanding. The interest on exchange notes would be payable at a rate of 7.50% per year semi-annually.

    Meeting with FDA

    On 2nd August, Protalix Biotherapeutics announced to have submitted a type-A meeting request to US Federal Drug Administration (FDA). The company requested the meeting to discuss the complete response letter issued by FDA about Biological License Application for its medicine pegunigalsidase alfa (PRX-102). According to the company, medicine aids in the treatment of Fabry disease. The type-A meeting usually occurs within 30 days of the FDA’s receipt of a meeting request.

    Investigations against PLX stock

    In recent months, different law firms have started investigations against Protalix on behalf of claims of Protalix investors. The investigations have started after, on the 2nd of June, Protalix provided an update about the clinical development of PRX-102. The company said that two of the participants had discontinued the treatment after Treatment-Emergent Adverse Events (TEAE’s). After this news broke, the PLX stock fell 17.44%.

    PLX Stock Q1 financial results

    In mid of May, the company released financial results for the first quarter of the fiscal year 2021. According to the details, the company recorded revenue of $4.5 million through the sales of goods during the quarter, which is a decrease of 10% when compared with the equivalent period of 2020. The cost of goods sold during the quarter stood at $4.8 million, which was an increase of 41% when compared with the statistics of an equivalent period of 2020. The net financial expenses stood at $1.8 million, a decrease of 40% when compared with the equivalent period of 2020. The net loss was $5.5 million, as compared to a net income of $1.7 million during the equivalent period of 2020. The company also announced that during the quarter, it had gained positive topline results from the phase III Bright clinical study, which was conducted to check the efficacy of PRX–102.

    What lies ahead?

    According to analysts, the company is expected to record revenue of $38.39 million during the next fiscal year. This and other alike figures reveal that although, a recent quarter hasn’t proved to be meaningful for the company, yet the future time holds something great in store for it. The earning per share during next year could increase by some 109.30%. This indicates the bloom in near future for PLX stock. So, potential investors should keep a close watch on PLX stock.

  • MARA Stock on the Rise Pre Hours. Here’s Why

    Marathon Digital Holdings Inc. (MARA), a digital asset technology company, experienced a decline of 3.81% in its share price on Thursday, as a result of which, the share price stood at $33.84. But, in the premarket hours, MARA stock is on rise. Up till now, it has experienced an increase of 4.31%, and as a result, the share price currently stands at $35.30.

    Appointment of Board of Directors

    On Monday, Marathon Digital appointed Sarita James and Said Ouissal to its board of directors. After that move, Marathon Digital’s board of directors consists of seven members. Sarita James is the CEO of Embark, which is a college admission software company and has been awarded several accolades, while Said Ouissal is the CEO and founder of ZEDEDA. He brings along himself a rich experience of leadership across IP networking, Telecommunications, and the mobile broadband industry. Both Sarita and Said have track records of successfully leading and growing organizations in industries directly pertinent to our own, as said by CEO of Marathon Digital Holdings, Fred Thiel.

    July update about bitcoin mining and production

    On the 3rd of August, the company shared an update regarding the Bitcoin production and mining operations for July. According to the update, the company had produced 442.2 new bitcoin during the month of July, as a result of which, its existing bitcoin number has reached 6225.5, having a market value of $260.7 million. The cash on hand was about $91.9 million. The existing mining fleet of the company consists of 19,395 miners, producing 2.09 EH/s.

    MARA Purchased Bitcoin mining setup

    On the 2nd of August, the company announced it have purchased the 30000 antiminerS19j Pro (100 TH/s) miners for a price of $120.7 million from Bitman. The company hopes to get all of the miners between January 2022 and June 2022. with this new order, they are growing operations by 30% to approximately 133,000 miners, producing 13.3 EH/s, said Fred Thiel.

    Appointment of Director of corporate communications

    In mid of July, the company announced to appoint Charlie Schumacher as director of corporate communications. Charlie is a communication strategist, having vast experience in leadership positions, as well as in capital markets navigation. Since 2017, he has been keenly studying the investment in Bitcoins and advising companies on the subject. Fried Thiel welcomed his induction into the company. Charlie, who has been working with us since September 2020, has proven to be a valuable resource for Marathon, and we look forward to further benefitting from his expertise, said Fred Thiel.

    June update about bitcoin mining and production

    In early July, the comp announced the Bitcoin production and mining update for the month of June 2021. According to those, the company had produce 265.5 new bitcoins in the month, while the cash on hand was $170.6 million. The company also announced to have increased the active mining fleet to 19,395 miners.

    What lies ahead for MARA stock?

    Digital assets are believed to be the key to unlocking the future potential of our finance sector. So, in that regard, the coming time appears to be sanguine for Marathon Holdings. As far as the performance of MARA stock is concerned, the EPS for next year is estimated to increase 41.50%. The short-term volatility in the market could affect MARA stock, but the long-term investors could remain in benefit keeping in mind the current performance of MARA stock.

  • Is Huobi Token (HT) a good Investment?

    Is Huobi Token (HT) a good Investment?

    Huobi Global (HT) is one of the most used exchanges in the world of cryptocurrency. The exchange was founded by Leon Li and Jun Du. The exchange is held in high regard as the platform allows you to exchange between hundreds of pairs.

    Huobi Token (HT) is the native token of the platform. Launched in 2018 the project is quite new in the world. Being rivals with coins such as BNB of Binance and KCS of KuCoin, HT faces tough competition in cryptocurrency.

    Huobi Token (HT) uses

    Huobi Token has multiple uses. HT can be used to reduce transaction fee on Huobi Global. The token can be used to purchase VIP status and makes them eligible for various rewards. People who hold HT are also eligible to vote on exchange decisions. People who hold Huobi Tokens also receive coins whenever new listing happens on the platform as a means of promotion. The platform also uses HT tokens as a form of insurance for the investors and compensates them in case they suffer some loss.

    HT Key Statistics

    There is a total of 500M tokens of HT out of which 60% were distributed and the remaining 40% are reserved. According to CoinMarketCap the token is ranked 52. With a market dominance of 0.12%, the coin is currently being traded at a price of 13.53%. HT has had an increase of 1.13% in the last day with an overall increase of 25.31% in the last 7 days. Huobi Token has achieved its All Time High on 13th May 2021 and had a price of $39.9.

    HT’s Recent Developments

    Recently the company has dissolved one of its entities called Beijing Huobi amidst the crackdown from Chinese Government and had stopped offering leverage trading to its users based in China. According to a company’s spokesperson, the Beijing Huobi was in its initial stages of development and was not in operation.

    Is Huobi Token (HT) a good investment?

    With new tokens listing every day and the way the exchange is giving rewards to its users and holders, we can see that the Huobi has a bright future ahead. The more exchange is used the more we can expect to people to buy Huobi Token as it offers so many rewards. The token can be purchased from a number of different exchanges. It can be expected of the coin that it breaks All Time High price and go into the price discovery phase in a year.

  • Telcoin (TEL) – Why hasn’t it rocketed yet?

    Telcoin (TEL) – Why hasn’t it rocketed yet?

    Telcoin (TEL) has been one of the most volatile coins in the market. The coin has had been consolidating with no real move in the market since the drop.  The coin went on to create its ALL TIME HIGH at a price of $0.064 on 11th May 2021. During this whole time, the coin created a bottom of $0.009. It was a fast wick down to the price before closing to a price of $0.02. Traders who caught the wick down are lucky enough to have more than 100% increases in that day alone. Currently, the coin is being traded at a price of $0.0197. According to CoinMarketCap, the coin has had a decrease of 6.55% in the last 24 hours but an overall increase of 14.94% in the last 7 days and has a total supply of 100B coins. The coin is currently ranked at 84 on the website.

    Telcoin (TEL) Technical Analysis

    Seeing the market on a daily timeframe, it’s clear that the market is behaving in a bearish trend since May 2021. It’s clearly making Lower Low & Lower High within a descending channel since then. Recently the market has showed some impulsive to the upside but on 26 July it has come across into consolidation again. The Telcoin market can’t be considered in an uptrend unless and until the level of 0.0309 level gets broken because it has been acting as the previous market structure i.e. Lower High. On 26 July and 11 August market tried to break the consolidation but was unable to do so leaving behind buy-side liquidity. The market tends to take out liquidity so it can be expected for the market to push up to 0.0299 before moving to 0.0120.

    Will TEL stay above the trend line?

    Moreover, at the moment the price hasn’t even broke the trend line, so to break it a huge volume will be required, which can never be guaranteed. Current support for the Telcoin is at around the price of $0.017 and the resistance around $0.022. Break either and we can expect a move. Confirmations on a lower time frame would be a plus for the movement.

    So what else can be expected? The market may never go for liquidity trapping bulls, and may directly fall down. This shall be decided on the BTC movement as to how it behaves in the upcoming days and how it gets manipulated by the major holders and news effects.

  • Crypto Trading: Here’s What You Should Keep in Mind

    Crypto Trading: Here’s What You Should Keep in Mind

    Honestly, Trading is addictive. Once you get used to it there is no back. Some people have made their fortunes while some have been unsuccessful. Here are a few important things that you should be keeping in your mind and these will help you a lot in crypto trading.

    Keep your Sentiments in Check

    First thing to keep in mind is to have a clear direction in your mind where the market is going to go. Don’t act on emotions and without any reason. Don’t develop a bias. Trade, don’t gamble.

    Try to look at the news with respect to the coin that you’re going to trade on. Is there positive news? Is there bad news? Is there any FUD being spread? How are these going to affect the price movement?

    Avoid entering into manipulative coins. These coins are difficult to trade and are very volatile and can show sudden changes. Rug Pulls can also happen in these coins. Beware.

    Don’t be greedy and don’t overtrade. Try to stick with minimum open trades at one time. Don’t sleep on one and use caution with newly launched coins.

    Technicals to Keep in Mind

    Have a good sense of risk and try to use minimum leverage on trades if you are new. It is recommended to stay in the spot if you are just starting from scratch.

    Before opening a trade, have a look at BTC and how it is performing. Is BTC stable or in the right direction? Go for it, otherwise, it is recommended to avoid uncertain scenarios.

    Don’t long the Top and don’t short the Bottom. Try to understand support and resistances and how the market respects these levels.

    Track OHLC (open, high, low, close) levels. It is important to know where the candle opens and closes.

    It is recommended to trade with at least 3 confirmations. Important confluences can be taken by:

    • Trend Line
    • S and R
    • MACD
    • RSI

    Use stop losses, a lot of people don’t use them because they think that the price is eventually going to come up. But use them and use them wisely. Typically 5% to 10% is used or the point below the nearest support.

    Always define your take profits (TP). When the trade is going good, don’t be greedy and take profits along the way. Decide TP levels before you start the trade.

    Buy the dips in a good moving market. But try to average your way in the market. If the price dumps to a certain level don’t enter all at once. Instead, invest some portion, and if the market dips further invest more.

    Lastly, making profits in the market is easier as compared to preserving your capital. Try to take minimum risk. Don’t invest something you can’t afford to lose.

  • ISUN Stock on a Rise in Premarket. Here’s Why

    ISUN Stock on a Rise in Premarket. Here’s Why

    iSun Inc. (ISUN), a provider of solar EPC services, bore a decrease of 1.75% in its share price on Thursday, and as a result, ISUN stock closed the day at $9.54. The company’s share price has increased some 6.39% after that decrease. Consequently, ISUN stock currently stands at $10.15.

    Accolade for company

    The company, on the 21st of July, announced that the Solar Power World, the leading news platform for tech, development, and installation-related news, has ranked ISUN as one of the top solar contractors in the US. The company’s overall ranking was 38th, and it was 3rd in the list for leading commercial and industrial EPC contractors in the United States.“We expect this growth to continue as we deploy our strategy across the residential, commercial, industrial, utility, and solar EV charging segments of our business”, said Jeffrey Peck, iSun’s Chief Executive Officer.

    Selection for EPS services

    On 23rd of June, iSun’s administration announced that it was selected by the Fusion Renewables for the trunkey development services and for EPC services, which is subjected to competitive tendering. The contract represents the construction of solar power projects at 8 sites in North and South Carolina, having a total power output of 118 Megawatt. Alongside that, the contract also represents initial developmental financing of $1.25 million. The investment is the first renewable energy investment for both of the companies in the US.“The iSun Team is well equipped to deliver turnkey projects to help propel the energy transition”, said Jeffery Peck.

    Induction into Russell Microcap Index

    In early June, the company was inducted into the Russell Microcap® Index at the conclusion of 2021 Russell indexes annual reconstitution. The induction would have to become effective from 28th of June. The membership of Russell Microcap® Index remains in place for one year. The membership of it means automatic inclusion in the appropriate growth and value style indexes.” We are very proud to be included in the Russell Microcap Index as recognition that our growth efforts since 2019 have been producing positive results”, said the CEO OF iSun.

    ISUN Stock Q1 financial results

    In late May, the company announced the quarterly results for first quarter of year 2021. According to the details, the company recorded the revenue of $7.3 million during the quarter, which is 82.2% higher when compared with the equivalent period of 2020, mainly due to the strong project awards in second half of 2020 and early part of 2021. The cash balance at the end of quarter stood at $20 million. The gross profit was $0.1 million, as compared to the $0.3 million in equivalent period of 2020. The operating loss during the quarter stands at $2.6 million, as compared to the $0.5 million in equivalent period of 2020.

  • Cytosorbents (CTSO) Stock Surged 4.13%, Here’s Why

    Cytosorbents Corp (NASDAQ: CTSO) is up 4.13% in the current market trading session at the price of $8.12 after the announcement of grant of second Breakthrough Device designation to DrugSorb-ATR.

    Grant of Second Breakthrough Device Designation to DrugSorb-ATR

    On 12th August 2021, CTSO announced that FDA Breakthrough designation had been granted to CytoSorbents’ DrugSorb-ATR. This Breakthrough Device designation helps the removal of Apixaban and Rivaroxaban to minimize the risk of bleeding during urgent cardiothoracic surgery.

    CTSO Second Quarter 2021 Financial Report

    On 3rd August 2021, CTSO announced financial and operating results for the second quarter and six months ending 30th June 2021. Total revenue for the second quarter of 2021 was $12.0 million, 23% up compared to $9.8 million in the same quarter of 2020. Second-quarter 2021 product sales grew 19% to $11.4 million compared to product sales of $9.5 million during Q2 2020. Gross profit increased to $9.3 million in the second quarter of 2021. The gross profit reported in the second quarter of 2020 was $6.5 million.

    CEO Dr. Phillip Chan remarked that they continue working on the U.S. STAR-T trial. It gives a low-risk, rapid, and most acceptable path to U.S. marketing approval. After full FDA approval of IDE application in July, they are ramping activities to begin enrollment. The first patient enrollment is expected this quarter, and the trial will be completed next year, he added.

    Target 100,000 International Fundraising Campaign to Counter COVID-19

    On 30th July 2021, CTSO declared the completion of its 100,000 international fundraising campaign to fight against COVID-19. A check of $100,000 was presented to CARE

    CARE is a global non-profit humanitarian organization. The funds raised for CARE’s Crisis Response Campaign will enable the organization to provide vaccinations, education, sanitation, and disinfectant initiatives to counter Covid-19.

    CEO Dr. Phillip Chan had thanked all of their friends, business partners, colleagues, employees, and shareholders for their generous donations. It enabled them to fulfill their commitment of raising $100,000 to support CARE’s COVID-19 Emergency Fund, he added.

    CTSO Received FDA Approval of Investigational Device Exemption for STAR-T Trial

    On 6th July 2021, CTSO published the full approval of its Investigational Device Exemption (IDE) application to conduct the pivotal STAR-T trial in the United States. This study was performed under the previously announced FDA Breakthrough Designation granted for the removal of ticagrelor in a cardiopulmonary bypass circuit.

    EfthymiosDeliargyris, Chief Medical Officer, commented that they are happy to announce that FDA has granted full IDE approval for the randomized, controlled, and double-blind STAR-T trial. The STAR-T is designed to support regulatory clearance of the DrugSorb-ATR Antithrombotic Removal system to remove intraoperative ticagrelor during cardiothoracic surgery.

    Appointment of Terri Anne Powers

    On 1st June 2021, CTSO reported the appointment of Terri Anne Powers as Vice President of Investor Relations and Corporate Communications. Powers is an expert in financial and communications with over 15 years of experience in the healthcare system. She was appointed to expand affiliations with the broader stakeholder community by building best-in-class investor relations and corporate communications functions.

    Future Expectations

    The company anticipates COVID-19 product sales for the rest of the year to be less than $1 million. It is expecting near 30% YoY growth in the second half of 2021 and 30% YoY growth in the full-year 2021 in non-COVID-19 product sales. Overall, it expects higher product sales in the second half of 2021 than the first half of 2021.

  • OncoCyte Corporation (OCX) Stock Surged 14.25%. Here’s Why

    OncoCyte Corporation (OCX) Stock Surged 14.25%. Here’s Why

    OncoCyte Corporation’s (NASDAQ: OCX) stock is up 14.25% in the current-market trading session at the price of $4.65 despite any recent news.

    OCX Stock Second Quarter 2021 Financial Results

    On 10th August 2021, OCX stock announced financial results for the second quarter ended on 30th June 2021 and a corporate update. Net loss was $9.1 million or $0.14 per share for the second quarter of 2020. For Q2 2021, a net loss of $10.5 million or $0.12 per share was reported. The total revenue for the second quarter of 2021 was $2.03 million. Net revenue of $0.1 million was reported in the same quarter of 2020.  High revenue was generated from DetermaRx tests, pharma services, and licensing revenues this quarter.

    CEO Ron Andrews commented that OCX Stock has continued working at its solid growth trajectory, driven by strategic gains. As per its commitment, the company is on a way to deliver and launch three products in the fourth quarter of 2021. They are motivated by their fast quarter-over-quarter sample volume growth with DetermaRx despite the endless pandemic, he added.

    Participation in Upcoming Investor Events

    On 9th August 2021, OCX stock declared the participation of management in two upcoming investor meetings. First, the “UBS Genomics 2.0 & MedTech Innovations Summit” was schedule to be held on Thursday, 12th August 2021, at Montage Laguna Beach. Second, “The 6th Annual Needham Virtual Med Tech & Diagnostics Conference” will be on Tuesday, 17th August 2021.

    OCX Stock Partnered with EchelonDx

    Oncocyte Corporation, on 15th June 2021, disclosed a strategic partnership with Echelon Diagnostics. The two firms will collaborate to develop analytical software that can scale to support the commercial expansion of Oncocyte’s tests. Moreover, they will work on solutions that can diagnose and treat cancer. Doug Ross, Chief Scientific Officer of OCX stock, commented that EchelonDx was the right partner which enabled them to build software solutions. Such solutions will help in scaling and launching the proprietary tests to ensure uniform and accurate results.

    Collaboration with GruppoOncologico del Nord Ovest

    On 3rd June 2021, OCX stock declared a strategic partnership with GruppoOncologico del Nord-Ovest of Pisa, Italy.  The goal was to evaluate DetermaIOOncocyte’s proprietary gene expression test. The test helps to evaluate the tumor immune microenvironment from a biopsy sample. This is the fifth tumor type being analyzed for DetermaIO. The first fours tests were being used to anticipate immune therapy response in lung, breast, bladder, and renal cancers.

  • Solana (SOL) coin price action; will it break through resistance?

    Solana (SOL) coin price action; will it break through resistance?

    Solana (SOL) made its ALL TIME HIGH at the price of $58.80. The coin has had a massive run in the past before failing to create a higher high. Currently, SOL coin is being traded at a price of $41.53. The coin has had a decrease of 2.99% in the last 24 hours and a total increase of 12.53% in the last 7 days. Volume has increased by 5.65% in the last day. The coin has a market dominance of 0.63% and is ranked 12 on CoinMarketcap.

    Solana (SOL) Coin Technical Analysis

    The coin rallied from around $22 and started printing green candles. SOL coin consolidated for a little time around $33. During this time the reversal of the market wasn’t confirmed on the daily time frame. But when it broke the line and moved upwards the reversal on a higher time frame was confirmed. The coin broke the structure at $37 and moved upwards to test at $43.7. SOL coin has a current resistance at $44.2. The coin has tried to test the zone in the last two days but failed to trip it.

    1 Hour Time Frame

    For further details, 1-hour time frame can be looked it. Notice that the price has been ranging in an ascending wedge. To study whether SOLcoin can be moving upwards or not we can look at if the coin broke the line or not. Confirmation came when a red candle was printed showing the sign of reversal on a lower time frame indicating that the coin may drop and retrace. Confluences come from the fact that the SOL coin has had a run and needs to breathe before continuing a leg up. Currently moving to print a Lower High. If it is formed, it can be expected to drop around $39.3 or $38. If this case prevails averaging can be used to enter the market. In a more bullish case, the rally can continue up to around $44 where a major resistance zone is in place. The price may respect the zone and show a pullback from it. The second resistance zone is at $49. 

    Tips for Entries

    Remember to take profits all along and to set stop losses as well. Entry should always be after additional confluences. To avoid maximum risk, look for lower time frames and decide. Always have a backup plan. FOMO’ing isn’t something that is encouraged. Always have patience when trading.